This site is intended for healthcare professionals
Latest industry news
  • Home
  • /
  • News
  • /
  • 2015
  • /
  • 04
  • /
  • Sorin S.p.A merges with Cyberonics Inc.
Industry news

Sorin S.p.A merges with Cyberonics Inc.

Read time: 1 mins
Last updated:15th Apr 2015
Published:15th Apr 2015
Source: Pharmawand
Sorin S.p.A., a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc.,a medical device company with core expertise in neuromodulation, announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, relating to their pending merger, has expired, thereby satisfying one of the conditions required to finalize the merger transaction. Sorin and Cyberonics entered into a merger agreement pursuant to which the two companies will combine in an all-stock transaction. The proposed combination of Sorin and Cyberonics will create a new premier global medical technology company. The transaction was unanimously approved by the boards of directors of both companies. Cyberonics a medical device company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy system, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy system uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy system in selected markets worldwide. Cyberonics also has CE Mark for Vitaria, providing autonomic regulation therapy for chronic heart failure.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.